GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Surgical Science Sweden SUS.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

61.35

-0.49%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 992.3m

FY2016FY2025

Net income

SEK 66.8m

FY2016FY2025

Free cash flow

SEK 68.1m

FY2016FY2025

Shareholders' equity

SEK 4.27bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 992.3mSEK 884.1mSEK 882.9mSEK 802.5mSEK 366.8mSEK 104.8mSEK 101.5mSEK 65.7mSEK 58.0mSEK 51.8m
Research and developmentSEK 191.4mSEK 196.1mSEK 181.6mSEK 172.8mSEK 65.7mSEK 16.6mSEK 16.9mSEK 13.7mSEK 8.3mSEK 7.8m
Operating incomeSEK 109.0mSEK 144.3mSEK 189.2mSEK 162.5mSEK 88.8mSEK 20.0mSEK 15.2m−SEK 4.1m−SEK 4.4m−SEK 200,000
Net incomeSEK 66.8mSEK 131.6mSEK 234.0mSEK 188.0mSEK 86.2mSEK 15.6mSEK 12.6m−SEK 4.5m−SEK 2.3mSEK 3.3m
Diluted earnings per share1.312.584.593.692.020.450.41-0.19-0.090.23

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 4.69bnSEK 5.48bnSEK 4.70bnSEK 4.65bnSEK 3.98bnSEK 472.3mSEK 456.2mSEK 99.7mSEK 98.9mSEK 63.7m
Cash and short-term investmentsSEK 616.4mSEK 968.2mSEK 634.4mSEK 433.7mSEK 316.7mSEK 87.2mSEK 69.2mSEK 38.5mSEK 38.5mSEK 3.8m
Total liabilitiesSEK 418.3mSEK 651.0mSEK 357.5mSEK 413.1mSEK 393.1mSEK 45.2mSEK 54.5mSEK 20.3mSEK 13.4mSEK 41.3m
DebtSEK 1.6mSEK 75.6mSEK 53.3mSEK 29.8mSEK 24.9mSEK 4.3mSEK 5.5mSEK 4.4mSEK 4.0mSEK 8.9m
Shareholders' equitySEK 4.27bnSEK 4.83bnSEK 4.35bnSEK 4.24bnSEK 3.59bnSEK 427.0mSEK 401.7mSEK 79.4mSEK 85.5mSEK 22.4m
Shares outstanding51m51m51m51m43m34m31m24m24m14m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsSEK 79.8mSEK 137.2mSEK 238.3mSEK 129.5mSEK 39.1mSEK 23.2mSEK 55.2mSEK 6.9mSEK 7.9mSEK 13.4m
Capital spending−SEK 11.7m−SEK 47.5m−SEK 44.1m−SEK 34.5m−SEK 14.4m−SEK 8.7m−SEK 8.9m−SEK 8.6m−SEK 12.1m−SEK 11.7m
Free cash flowSEK 68.1mSEK 89.7mSEK 194.2mSEK 94.9mSEK 24.7mSEK 14.5mSEK 46.3m−SEK 1.8m−SEK 4.2mSEK 1.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 254.5mSEK 235.5mSEK 268.9mSEK 263.6mSEK 209.2mSEK 250.7mSEK 251.5mSEK 231.8m
Operating incomeSEK 43.7mSEK 22.9mSEK 47.0mSEK 27.2m−SEK 22.4mSEK 23.9mSEK 39.1mSEK 45.8m
Net incomeSEK 20.9mSEK 18.6mSEK 33.3mSEK 20.4m−SEK 20.1mSEK 33.2mSEK 36.3mSEK 43.0m
Diluted earnings per share0.410.370.650.40-0.390.650.710.84
Cash from operationsSEK 15.0mSEK 65.0mSEK 72.0m−SEK 4.0mSEK 16.0m−SEK 4.0mSEK 56.0mSEK 22.0m
Capital spending−SEK 7.0m−SEK 17.0m−SEK 6.0m−SEK 10.0m−SEK 12.0m−SEK 10.0m−SEK 12.0m−SEK 12.0m
Free cash flowSEK 8.0mSEK 48.0mSEK 66.0m−SEK 14.0mSEK 4.0m−SEK 14.0mSEK 44.0mSEK 10.0m
Total assetsSEK 4.97bnSEK 4.80bnSEK 4.69bnSEK 4.70bnSEK 4.71bnSEK 4.90bnSEK 5.48bnSEK 4.80bn
Cash and short-term investmentsSEK 658.4mSEK 667.7mSEK 616.4mSEK 597.4mSEK 610.2mSEK 612.9mSEK 968.2mSEK 666.3m
Debt—SEK 2.1mSEK 1.6mSEK 3.3mSEK 3.3mSEK 3.3m——
Shareholders' equitySEK 4.55bnSEK 4.42bnSEK 4.27bnSEK 4.30bnSEK 4.31bnSEK 4.48bnSEK 4.83bnSEK 4.45bn

Financial ratios

Data as of 1 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin11.0%18.5%30.5%28.4%24.2%19.1%
Net margin6.7%14.9%26.5%23.4%23.5%14.9%
Return on equity1.6%2.7%5.4%4.4%2.4%3.7%
Return on assets1.4%2.4%5.0%4.0%2.2%3.3%
Free cash flow yield3.0%6.2%9.4%5.5%2.1%1.6%
Revenue growth12.2%0.1%10.0%118.8%250.0%3.2%
Earnings growth-49.2%-43.7%24.5%117.9%452.7%23.9%
Current ratio4.07x2.78x4.22x2.70x2.65x4.26x
Debt to equity0.01x0.05x0.00x0.00x0.05x0.01x
Equity ratio91.1%88.1%92.4%91.1%90.1%90.4%
Interest coverage17.34x28.83x409.94x174.45x3.87x37.55x
R&D as a share of sales19.3%22.2%20.6%21.5%17.9%15.8%
Buybacks as a share of market value-0.0%0.0%-0.2%-19.3%-23.7%-13.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue7.3%56.8%35.9%
Operating income-12.5%40.4%50.7%
Net income-29.2%33.8%45.2%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin13.5%17.0%17.7%16.6%
Net margin10.6%17.4%17.9%16.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings24.824.216.017.955.982.982.4-43.2-64.8
Price to sales1.73.64.24.213.112.310.23.02.5

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 5-for-1 split · 25 May 2020

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.